Ruijuan Sun
About
Ruijuan Sun is a scholar working on Public Health, Environmental and Occupational Health, Oncology and Hematology.
According to data from OpenAlex, Ruijuan Sun has authored 37 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 13 papers in Oncology and 12 papers in Hematology. Recurrent topics in Ruijuan Sun's work include Acute Lymphoblastic Leukemia research (13 papers), CAR-T cell therapy research (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Ruijuan Sun is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), CAR-T cell therapy research (11 papers) and Hematopoietic Stem Cell Transplantation (10 papers). Ruijuan Sun collaborates with scholars based in China, India and Japan. Ruijuan Sun's co-authors include Jia Xiao, Bin Gao, Mingming Meng, Yanying Xu, Yingxia Liu, Nai-Kei Wong, Hua Wang, Xiaowei Liu, Hong You and Fei Wang and has published in prestigious journals such as Blood, Journal of Hepatology and Frontiers in Immunology.
In The Last Decade
Ruijuan Sun
29 papers receiving 623 citations
Hit Papers
Peers
Ruijuan Sun
Hussein Sheashaa Egypt
Julio Dávila Spain
Ayman Ibrahim United States
Hubert Hayden Austria
Katryn N. Furuya United States
Fernando Magdaleno Spain
Layla Shojaie United States
Yixin Zhang China
Yuting Wang China
Citations per year, relative to Ruijuan Sun Ruijuan Sun (= 1×)
peers
Hussein Sheashaa
Countries citing papers authored by Ruijuan Sun
Since
Specialization
Citations
This map shows the geographic impact of Ruijuan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruijuan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruijuan Sun more than expected).
Fields of papers citing papers by Ruijuan Sun
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ruijuan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruijuan Sun. The network helps show where Ruijuan Sun may publish in the future.
Co-authorship network of co-authors of Ruijuan Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Ruijuan Sun. A scholar is included among the top collaborators of Ruijuan Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruijuan Sun. Ruijuan Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Chen, Xue, Lili Yuan, Xiaoli Ma, et al.. (2025). Challenging the prognostic expectations: a rare case of ZNF618::NUTM1-positive B-cell lymphoblastic leukemia with poor outcome. PubMed. 7(2). e00230–e00230.
2.
Liu, Qifa, Na Xu, Fen Huang, et al.. (2025). Decitabine combined with reduced-intensity conditioning for older patients with acute myeloid leukemia in composite complete remission undergoing allogeneic hematopoietic stem cell transplantation: a multicenter, single-arm, phase 2 trial. The Lancet Regional Health - Western Pacific. 61. 101664–101664.
3.
Liu, Shiqi, Ying Dong, Zhiping Fan, et al.. (2024). Intensified conditioning containing decitabine versus standard myeloablative conditioning for adult patients with KMT2A-rearranged leukemia: a multicenter retrospective study. BMC Medicine. 22(1). 605–605.
4.
Zhang, Jianping, Yue Lü, Yanli Zhao, et al.. (2024). A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy. British Journal of Haematology. 204(6). 2351–2364.
5.
Zhong, Yuan, Ruijuan Sun, Wei Li, et al.. (2024). Risk factors for esophageal anastomotic stricture after esophagectomy: a meta-analysis. BMC Cancer. 24(1). 872–872.
6.
Wang, Tong, Yang Zhang, Fang Wang, et al.. (2023). Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation. Leukemia & lymphoma. 64(13). 2133–2139.
7.
Zhu, Huili, Xingyu Cao, Yue Lü, et al.. (2023). Efficacy and Safety Analysis of Prophylactic Brentuximab Vedotin Administration after Pediatric Acute Leukemia Haploidentical Hematopoietic Stem Cell Transplantation. Blood. 142(Supplement 1). 7009–7009.
8.
Cao, Xingyu, Jianping Zhang, Yanli Zhao, et al.. (2023). Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant. Frontiers in Immunology. 14. 1191382–1191382.
9.
Lü, Yue, Jianping Zhang, Yanli Zhao, et al.. (2023). Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study. Frontiers in Immunology. 13. 1066748–1066748.
10.
Shan, Zhiyan, Lijun Ding, Caiyun Zhu, Ruijuan Sun, & Wei Hong. (2022). Medical care of rare and undiagnosed diseases: Prospects and challenges. Fundamental Research. 2(6). 851–858.
11.
Wang, Juejin, et al.. (2022). Applications and grants of National Natural Science Foundation of China’s General Program in cardiovascular research: a 10-year review. Science China Life Sciences. 66(3). 649–652.
12.
Lü, Yue, Min Xiong, Ruijuan Sun, et al.. (2022). Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study. Leukemia & lymphoma. 63(14). 3307–3316.
13.
Zhao, Yanli, Deyan Liu, Ruijuan Sun, et al.. (2021). Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology. 12. 605766–605766.
14.
Lü, Yue, Yanli Zhao, Jianping Zhang, et al.. (2020). Comparable outcomes among unmanipulated haploidentical, matched unrelated, and matched sibling donors in BU-based myeloablative hematopoietic stem cell transplantation for intermediate and adverse risk acute myeloid leukemia in complete remission: a single-center study. Annals of Hematology. 100(6). 1579–1591.
15.
Lü, Yue, Yanli Zhao, Min Xiong, et al.. (2020). Unmanipulated haplo-identical donor transplantation compared with identical sibling donor had better anti-leukemia effect for refractory/relapsed acute myeloid leukemia not in remission status. Annals of Hematology. 99(12). 2911–2925.
16.
Liao, Shujie, et al.. (2019). National natural science foundation of China leads the comprehensive development of basic research in the field of male reproductive health in China. Asian Journal of Andrology. 22(6). 547–547.
17.
Xiao, Jia, Fei Wang, Nai-Kei Wong, et al.. (2019). Global liver disease burdens and research trends: Analysis from a Chinese perspective. Journal of Hepatology. 71(1). 212–221.
18.
He, Xiaojuan, Moshi Song, Jing Qu, et al.. (2019). Basic and translational aging research in China: present and future. Protein & Cell. 10(7). 476–484.
19.
Lü, Yue, Ruijuan Sun, Yanli Zhao, et al.. (2018). Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 24(9). 1881–1887.
20.
Zhu, Yuangui, Ruijuan Sun, & Erdan Dong. (2016). Heart failure research in China: current status and future direction. Science Bulletin. 61(23). 1793–1801.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Hussein Sheashaa Breakdown of academic impact, for papers by Julio Dávila Breakdown of academic impact, for papers by Ayman Ibrahim Breakdown of academic impact, for papers by Hubert Hayden Breakdown of academic impact, for papers by Katryn N. Furuya Breakdown of academic impact, for papers by Fernando Magdaleno Breakdown of academic impact, for papers by Layla Shojaie Breakdown of academic impact, for papers by Yixin Zhang Breakdown of academic impact, for papers by Yuting Wang